Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

496

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

July 31, 2010

Conditions
Type II Diabetes Mellitus
Interventions
DRUG

JTT-130

Tablets

DRUG

JTT-130 Placebo

Tablets

Trial Locations (62)

Unknown

Birmingham

Muscle Shoals

Scottsboro

Tucson

Encino

Los Angeles

Sacramento

Spring Valley

Valley Village

Walnut Creek

Waterbury

Delray Beach

Hialeah

Miami

New Port Richey

Ocala

Sandy Springs

Chicago

Indianapolis

Erlanger

Lexington

Louisville

Madisonville

Paducah

New Hyde Park

Greensboro

Morehead City

Statesville

Cincinnati

Marion

Tulsa

Eugene

Portland

Charleston

Greer

North Charleston

Bristol

Austin

Corpus Christi

Dallas

Houston

San Antonio

Salt Lake City

Manassas

Richmond

Bellevue

Olympia

Oregon

Beroun

Brno

Ostrava

Pardubice

Prague

Velké Hoštice

Sátoraljaújhely

Szikszó

Eindhoven

Groningen

Arkhangelsk

Moscow

Nizhny Novgorod

Saint Petersburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Akros Pharma Inc.

INDUSTRY

NCT00929539 - Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients | Biotech Hunter | Biotech Hunter